merged_eli-lilly-zepbound-price.txt
<question_number>1</question_number>
<answer>FDA-approved medication controlled for safety, quality, and effectiveness</answer>

<question_number>2</question_number>
<answer>Offers online prescriptions and direct-to-door delivery of vials, similar to telehealth companies</answer>

<question_number>3</question_number>
<answer>Lack of FDA oversight and control for safety, quality, and effectiveness</answer>

<question_number>4</question_number>
<answer>To regain customers currently using compounded tirzepatide</answer>

<question_number>5</question_number>
<answer>Compounding pharmacies can legally produce drugs listed as "in shortage" by the FDA</answer>

<question_number>6</question_number>
<answer>Offers "transparent pricing" by removing third-party supply chain entities</answer>

<question_number>7</question_number>
<answer>Older patients on Medicare might seek out cheaper Zepbound vials, despite potential risks</answer>

<question_number>8</question_number>
<answer>Positions Zepbound vials as a safer alternative to compounded drugs</answer>

<question_number>9</question_number>
<answer>Listed as "in shortage" by the FDA</answer>

<question_number>10</question_number>
<answer>Lowering prices to compete with compounded versions</answer>